<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Novartis leukemia drug gets FDA priority review for potential leukemia treatment Tasigna</title>
	<atom:link href="http://styplon.net/novartis-leukemia-drug-gets-fda-priority-review-for-potential-leukemia-treatment-tasigna/feed/" rel="self" type="application/rss+xml" />
	<link>http://styplon.net/novartis-leukemia-drug-gets-fda-priority-review-for-potential-leukemia-treatment-tasigna/</link>
	<description>styplon online</description>
	<pubDate>Fri, 18 May 2012 23:31:41 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.5</generator>
	</channel>
</rss>

